Back to Results
First PageMeta Content



CHINA’S LIFE SCIENCE INDUSTRYDear Colleagues and friends, With this edition of XinTech’s China Newsletter we are happy to announce the closing and signing of the first cross-border licensing and co-development
Add to Reading List

Document Date: 2014-07-10 10:30:24

Open Document

File Size: 641,70 KB

Share Result on Facebook

City

San Francisco / Guangzhou / /

Company

GZ Sunray Medical Apparatus / Trig Medical / Johnson & Johnson / Fosun Pharma / Sinopharm Group Co. / Schering-Plough / Wanbang Biopharmaceuticals / /

Country

Japan / United States / Macau / China / Singapore / Israel / /

Currency

USD / CNY / HKD / /

Event

Business Partnership / IPO / Funding / FDA Phase / /

Facility

California Institute / University of California / UCSF Medical Center / /

IndustryTerm

biopharmaceutical / technology startups / objective tool / pharmaceutical ingredients / stroke prevention treatment / pharmaceutical industry / non-invasive solution / manufacturing hub / pharmaceutical distributor / pharmaceutical market / cancer treatment / patent law / pharmaceutical groups / all-out pharmaceutical powerhouse / pharmaceutical co-development / /

MedicalCondition

cancer / stroke / /

NaturalFeature

Mission Bay / /

Organization

UCSF Medical Center / Chinese Pharmaceutical Enterprises Association / FDA / University of California / San Francisco / California Institute for Regenerative Medicine / /

Person

Haibo Wang / /

Position

general manager of the company / Eyal Harel Co-CEO POLICY / market leader in the O&G sector / market leader / /

Product

Doxil / D-Pharm's DP-b99 drug / /

ProvinceOrState

Jiangsu Province / North Carolina / California / /

Technology

US FDA protocol / drug development / Regenerative Medicine / /

SocialTag